Trial intelligence / Profile preview

Intra-articular Anesthetic and Aspiration in Tibial Plateau Fractures

NCT02951884Phase 4Terminated

Sponsor
Loyola University Chicago
Start
Jun 2016
Primary completion
May 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of bupivacaine in tibial plateau fracture (3 arms), sponsored by Loyola University Chicago. Primary endpoint: Numerical Rating Scale Pain Scores at 24 hours. Started Jun 2016; status: terminated.

02

Drugs

bupivacaine
03

Conditions

tibial plateau fracture

Beyond the preview

Go deeper on NCT02951884.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02951884.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call